Lifecore Cash And Short Term Investments from 2010 to 2024
| LFCR Stock | 5.91 0.15 2.48% |
Cash And Short Term Investments | First Reported 1996-02-29 | Previous Quarter 3 M | Current Value 19.1 M | Quarterly Volatility 19.2 M |
Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.4 M, Interest Expense of 19.1 M or Total Revenue of 98.1 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.74. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
Lifecore | Cash And Short Term Investments |
Latest Lifecore Biomedical's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Lifecore Biomedical over the last few years. Short Term Investments is an account in the current assets section of Lifecore Biomedical balance sheet. This account contains Lifecore Biomedical investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Lifecore Biomedical fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Lifecore Biomedical's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifecore Biomedical's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Lifecore Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 9,112,857 | |
| Geometric Mean | 5,181,167 | |
| Coefficient Of Variation | 81.40 | |
| Mean Deviation | 6,594,800 | |
| Median | 9,894,000 | |
| Standard Deviation | 7,417,684 | |
| Sample Variance | 55T | |
| Range | 21.8M | |
| R-Value | (0.44) | |
| Mean Square Error | 47.7T | |
| R-Squared | 0.19 | |
| Significance | 0.10 | |
| Slope | (731,168) | |
| Total Sum of Squares | 770.3T |
Lifecore Cash And Short Term Investments History
About Lifecore Biomedical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Lifecore Biomedical income statement, its balance sheet, and the statement of cash flows. Lifecore Biomedical investors use historical funamental indicators, such as Lifecore Biomedical's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may use each financial statement separately, they are all related. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lifecore Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lifecore Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lifecore Biomedical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 19.1 M | 13.4 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.